Literature DB >> 8531833

Carbamylation of proteins and atherogenesis in renal failure.

H E Roxborough1, I S Young.   

Abstract

The incidence of atherosclerosis is greatly increased in patients with chronic renal failure, and this increased risk is only partly explained by conventional risk factors. Carbamylation of proteins occurs in renal failure as a result of reactions between urea-derived cyanate and protein amino groups. A mechanism is proposed whereby oxidation of LDL cholesterol within the arterial wall may be enhanced as a result of carbamylation. This may be accentuated as a result of inhibition of antioxidant enzymes by carbamylation. The combination of these processes may lead to increased atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8531833     DOI: 10.1016/0306-9877(95)90059-4

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  4 in total

1.  Isolation and solubilization of proteins after TRIzol extraction of RNA and DNA from patient material following prolonged storage.

Authors:  Amanda B Hummon; Sharlene R Lim; Michael J Difilippantonio; Thomas Ried
Journal:  Biotechniques       Date:  2007-04       Impact factor: 1.993

2.  Carbamylated-oxidized LDL: proatherosclerotic effects on endothelial cells and macrophages.

Authors:  Eugene O Apostolov; Ercan Ok; Samuel Burns; Safia Nawaz; Alena Savenka; Sudhir V Shah; Alexei G Basnakian
Journal:  J Atheroscler Thromb       Date:  2013-09-25       Impact factor: 4.928

3.  Chronic increase of urea leads to carbamylated proteins accumulation in tissues in a mouse model of CKD.

Authors:  Christine Pietrement; Laëtitia Gorisse; Stéphane Jaisson; Philippe Gillery
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

Review 4.  Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.

Authors:  Alexander N Orekhov; Yuri V Bobryshev; Igor A Sobenin; Alexandra A Melnichenko; Dimitry A Chistiakov
Journal:  Int J Mol Sci       Date:  2014-07-21       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.